World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT01572636
Date of registration: 04/04/2012
Prospective Registration: No
Primary sponsor: Masonic Cancer Center, University of Minnesota
Public title: Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
Scientific title: MT2011-21C Laronidase (Aldurazyme TM) Enzyme Replacement Therapy (ERT) With Hematopoietic Stem Cell Transplantation (HSCT) for Hurler Syndrome (MPS IH).
Date of first enrolment: March 28, 2012
Target sample size: 20
Recruitment status: Terminated
URL:  https://clinicaltrials.gov/show/NCT01572636
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Paul Orchard, M.D.
Address: 
Telephone:
Email:
Affiliation:  Masonic Cancer Center, University of Minnesota
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of mucopolysaccharidosis type IH (MPS I, Hurler syndrome) and being
considered as a candidate for first transplant according to a University of Minnesota
myeloablative hematopoietic stem cell transplant (HSCT) protocol

Exclusion Criteria:

- No prior therapy with laronidase enzyme replacement therapy (ERT)



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Hurler Syndrome
MPS I
Mucopolysaccharidosis Type IH
Intervention(s)
Drug: Laronidase
Primary Outcome(s)
Overall Survival [Time Frame: At 1 Year]
Secondary Outcome(s)
Incidence of Grade III-IV Acute Graft Versus Host Disease [Time Frame: Day 100]
Incidence of Engraftment [Time Frame: 1 Year Post Transplant]
Proportion of patients in need of ventilator support [Time Frame: 1 Year]
Secondary ID(s)
MT2011-21C
2011OC140
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history